immunoreaction

(redirected from immunoreactivity)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to immunoreactivity: anamnestic

im·mu·no·re·ac·tion

(im'yū-nō-rē-ak'shŭn),
An immunologic reaction, especially in vitro between antigen and antibody.

immunoreaction

(ĭm′yə-nō-rē-ăk′shən, ĭ-myo͞o′-)
im′mu·no·re·ac′tive adj.
im′mu·no·re′ac·tiv′i·ty n.

immunoreaction

(ĭ-mū″nō-rē-ăk′shŭn)
The reaction of an antibody to an antigen, exploited in some laboratory tests that stain, isolate, or purify cells that express specific markers on their cell membranes.
References in periodicals archive ?
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
In the GLE-sham group, SOD1 immunoreactivity in neurons of the stratum pyramidale was significantly higher (about 134% of the vehicle-sham group) than that in the vehicle-sham group [Figure 4]b and [Figure 4]m.
We suggest that such a shift of I-T-C immunoreactivity in GF studies could be used as a criterion for the presence of TnAAbs in the samples considered together with the testing of the I-T-C recovery in the TnI19C7TnI560 assay.
Immunoreactivity reduction of soybean meal by fermentation, effect on amino acid composition and antigenicity of commercial soy products.
Ischemic damage induced a considerable increase in Tau-1 immunoreactivity in the acute phase after focal ischemia (Figure 7).
The tumor cells showed cytoplasmic immunoreactivity for vimentin and were negative for S100 and myogenin.
Metastatic renal cell carcinoma shows a lack of immunoreactivity for thyroglobulin and TTF-1 but shows immunoreactivity for cytokeratin, CD10, and vimentin.
F: Immunohistochemically positive immunoreactivity with histiocyte marker CD68 in multinuclear giant cells (immunostains, original magnification x400).
At the surface of the pedal sole there is intense immunoreactivity to 5HT antibodies, but only on the musculature of the pedal wave area, and not on the rim of the pedal sole.
Scoring of immunoreactivity in stained tissues calculated semi quantitatively by the percentage of retention density in each group muscles as H score (HS) and classified as 0 (0, no retention), 1 (+, weak immunoreactivity), 2 (++, medium immunoreactivity), 3 (+++, strong immunoreactivity).
Immunohistochemical analysis revealed that in saline-treated subgroups, immunoreactivity was more pronounced for all apoprosis-inducing proteins compared to bevacizumab-treated group.

Full browser ?